An anti-P40 recombinant rabbit monoclonal antibody and its application
By developing high specificity and high sensitivity anti-P40 recombinant rabbit monoclonal antibodies, the problem of insufficient specificity of P40 antibodies in the prior art was solved, and accurate identification and distinction between lung squamous cell carcinoma and lung glands were achieved in immunohistochemical detection. The ability to cancer.
Patent Information
- Application Number
- CN202411106849.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-08-13
AI Technical Summary
The existing commercially available P40 recombinant rabbit monoclonal antibodies are insufficient in specificity and have weak positive signals, making it difficult to accurately distinguish between lung squamous cell carcinoma and lung adenocarcinoma in immunohistochemical detection.
A anti-P40 recombinant rabbit monoclonal antibody was developed to obtain high specificity and high sensitivity antibodies through recombinant expression of mammalian cells using specific peptide antigens and molecular cloning techniques. It is suitable for immunohistochemistry detection, including immunohistochemistry, Indirect ELISA, immunoimprinting and antibody chip preparation.
The antibody is able to recognize and detect the expression of P40 protein with high specificity, providing a strong positive signal, improving the accuracy of evaluation in IHC staining and the ability to distinguish cancers.
Smart Images

Figure CN118620077B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of immunochemistry, and in particular relates to an anti-P40 recombinant rabbit monoclonal antibody and an application thereof, in particular to an application in immunohistochemical detection. Background Art
[0002] P40 is one of the subtypes of P63 protein, with a molecular weight of 40KD. In daily pathological diagnosis, P63 is widely used in lung cancer typing. It has a high sensitivity in lung squamous cell carcinoma, but is also partially expressed in lung adenocarcinoma. Compared with P63, P40 has a high sensitivity similar to that of P63 antibody in lung squamous cell carcinoma, but is rarely expressed in lung adenocarcinoma. Therefore, P40 is recommended for differential diagnosis of lung squamous cell carcinoma and lung adenocarcinoma.
[0003] However, the specificity of the P40 recombinant rabbit monoclonal antibody currently on the market needs to be optimized, and the positive signal is weak, which is not conducive to detecting and distinguishing cancer in IHC staining. Pathology experts are usually required to evaluate the staining results based on clinical history, morphology and other histopathological criteria. Summary of the invention
[0004] 1. Technical issues to be resolved
[0005] In view of the above shortcomings and deficiencies of the prior art, the present invention provides an anti-P40 recombinant rabbit monoclonal antibody that is widely used and can accurately identify P40 expression. After immunohistochemical detection of various different tissues, it is found that the antibody can well detect the expression of P40 protein on tumor cells, and can be applied to detection and screening fields such as immunohistochemistry (IHC), indirect ELISA, Western blotting, and antibody chip preparation. The present invention also relates to a nucleotide sequence encoding the anti-P40 recombinant rabbit monoclonal antibody, a recombinant plasmid or expression vector, a preparation method, and the application of the anti-P40 recombinant rabbit monoclonal antibody in a P40 protein detection method or device.
[0006] (II) Technical solution
[0007] In order to achieve the above object, the main technical solutions adopted by the present invention include:
[0008] In a first aspect, the present invention provides an anti-P40 recombinant rabbit monoclonal antibody, which comprises a heavy chain variable region and a light chain variable region, wherein the amino acid sequence of the heavy chain variable region is shown in SEQ ID NO: 4; and the amino acid sequence of the light chain variable region is shown in SEQ ID NO: 5.
[0009] The anti-P40 recombinant rabbit monoclonal antibody (P40 rabbit antibody) can be used for immunohistochemical detection, and can identify and detect the expression of P40 protein on tumor cells or immune cells with high specificity and sensitivity.
[0010] The anti-P40 monoclonal antibody is obtained by recombinant expression of mammalian cells. Specifically, the anti-P40 recombinant rabbit monoclonal antibody provided by the present invention is produced by rabbit hybridoma fusion screening and 293 cell eukaryotic expression. When preparing the anti-P40 monoclonal antibody, the antigen used to immunize the rabbit (New Zealand white rabbit) is a synthetic polypeptide, and the amino acid sequence of the synthetic polypeptide is shown in SEQ ID NO: 1, which is obtained by artificial chemical synthesis. After immunizing the rabbit, a positive hybridoma cell line that can efficiently secrete monoclonal antibodies is obtained through cell fusion and cloning screening, and a nucleotide sequence encoding the heavy chain amino acid sequence and light chain amino acid sequence of the antibody is obtained using molecular cloning technology, and the nucleotide sequence is constructed on a eukaryotic expression vector, transfected into a 293 cell line by a transfection reagent, and the cell supernatant is collected. Purify the cell supernatant by protein A column affinity chromatography to obtain a rabbit monoclonal antibody. Immunohistochemical detection shows that the antibody can specifically recognize the P40 protein.
[0011] The anti-P40 monoclonal antibody can recognize the recombinant P40 antigen protein and the P40 molecules on tumor cells and immune cells; the anti-P40 monoclonal antibody can also be used in immunohistochemical pathological diagnostic agents.
[0012] In a second aspect, the present invention provides a coding gene for encoding the above-mentioned anti-P40 recombinant rabbit monoclonal antibody.
[0013] Preferably, the encoding gene includes a DNA sequence as shown in SEQ ID NO: 2 or a sequence complementary thereto, which is used to encode the heavy chain variable region of the anti-P40 recombinant rabbit monoclonal antibody; and a DNA sequence as shown in SEQ ID NO: 3 or a sequence complementary thereto, which is used to encode the light chain variable region of the anti-P40 recombinant rabbit monoclonal antibody.
[0014] In a third aspect, the present invention relates to a nucleic acid molecule comprising a gene encoding the anti-P40 recombinant rabbit monoclonal antibody.
[0015] In a fourth aspect, the present invention provides an expression vector or a recombinant plasmid, which comprises the above-mentioned nucleic acid molecule.
[0016] In a fifth aspect, the present invention provides a host cell transformed or transfected with the above-mentioned expression vector or recombinant plasmid.
[0017] In a sixth aspect, the present invention provides a method for preparing an anti-P40 recombinant rabbit monoclonal antibody, comprising transforming or transfecting host cells with the above-mentioned expression vector or recombinant plasmid, continuing to culture the cells, collecting and purifying the cell supernatant, and obtaining the anti-P40 recombinant rabbit monoclonal antibody.
[0018] In a seventh aspect, the present invention further provides a P40 detection kit, which comprises the above-mentioned anti-P40 recombinant rabbit monoclonal antibody and an immunohistochemical detection reagent.
[0019] Preferably, the P40 detection kit comprises: anti-P40 recombinant rabbit monoclonal antibody, HRP enzyme-labeled secondary antibody, EDTA repair solution, catalase blocking solution, DAB concentrate, DAB buffer, hematoxylin and bluing solution.
[0020] When performing immunohistochemistry detection, the detection steps include dewaxing, antigen retrieval, endogenous peroxidase inactivation, blocking, primary antibody incubation, secondary antibody incubation, 3,3'-diaminobenzidine (DAB) color development, counterstaining, dehydration, sealing and microscopic examination.
[0021] (III) Beneficial effects
[0022] The anti-P40 recombinant rabbit monoclonal antibody provided by the present invention has high specificity and high sensitivity in combination with the P40 protein molecule, can specifically identify and detect the expression of the P40 protein on cells, and is positively highly expressed when detecting the P40 protein. Therefore, the antibody can be applied to detection and screening fields such as immunohistochemistry (IHC), indirect ELISA, Western blotting, antibody chip preparation, flow cytometry, etc., which is conducive to obtaining accurate evaluation and detection results. The P40 recombinant rabbit monoclonal antibody cloned by 513M2A7 of the present invention is easier to score in IHC staining due to its good specificity and strong positive signal, and is more accurate for detecting and distinguishing cancer. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The immunohistochemical detection results of the 513M2A7 anti-P40 monoclonal antibody prepared by the present invention and the commercially available antibody in human squamous cell lung cancer, normal breast, and tonsil tissues, the use concentration of the 513M2A7 anti-P40 monoclonal antibody is 1 μg / mL; wherein a is the immunohistochemical detection result of the P40 antibody cloned by 513M2A7 in squamous cell lung cancer, and b is the immunohistochemical detection result of the commercially available antibody in squamous cell lung cancer (a and b have the same magnification); c is the immunohistochemical detection result of the P40 antibody cloned by 513M2A7 in normal breast, and d is the immunohistochemical detection result of the commercially available antibody in normal breast (c and d have the same magnification); e is the immunohistochemical detection result of the P40 antibody cloned by 513M2A7 in tonsil, and f is the immunohistochemical detection result of the commercially available antibody in tonsil tissue (e and f have the same magnification);
[0024] Figure 2 It is a statistical graph of the titer detection of the 513M2A7 anti-P40 monoclonal antibody of the present invention and commercially available antibodies at 8 gradient concentrations;
[0025] Figure 3 The immunoblotting (Western blotting) test results of the 513M2A7 anti-P40 monoclonal antibody of the present invention as a primary antibody verify its recognition ability for the P40 protein. DETAILED DESCRIPTION
[0026] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to explain the present invention, rather than to limit the present invention.
[0027] If no specific technology or conditions are specified in the examples, the technology or conditions described in the literature in the field or the product instructions are used. If the manufacturer of the reagents or instruments used is not specified, they are all conventional products that can be purchased through regular channels. Human tissue samples are formalin-fixed and paraffin-embedded human tissue samples, all of which have been pathologically confirmed and have informed consent from patients.
[0028] Example 1
[0029] This example is the preparation and screening of anti-P40 recombinant rabbit monoclonal antibodies, and the steps include:
[0030] (1) Antigen preparation
[0031] The specific sequence of P40 antigen is shown in SEQ ID NO: 1 below.
[0032] SEQ ID NO: 1 is: ENNAQTQFSEPQY.
[0033] The above polypeptide sequence is selected by analyzing the P40 molecular sequence based on the structure, antigenicity, hydrophilicity and secondary structure of the P40 protein molecule. The polypeptide of the sequence shown in SEQ ID NO: 1 is artificially synthesized, and the synthesized polypeptide is used as an antigen for immunizing rabbits. During immunization, the polypeptide of the sequence shown in SEQ ID NO: 1 is coupled with KLH and used as an immunogen to immunize rabbits.
[0034] (2) Immunity
[0035] The polypeptide sequence of SEQ ID NO: 1 (P40 antigen) was mixed and emulsified with complete Freund's adjuvant (volume ratio 1: 1), and multiple New Zealand white rabbits were immunized by subcutaneous injection. After two weeks, the P40 antigen containing the above sequence (the polypeptide shown in SEQ ID NO: 1) was emulsified with incomplete Freund's adjuvant (volume ratio 1: 1) for the second and third immunizations. After the three immunizations, blood was collected and the serum titer was determined by gradient dilution by ELISA method; the rabbit with the highest antibody titer immunized with SEQ ID NO: 1 antigen was selected for the next step of cell fusion.
[0036] (3) Cell fusion
[0037] Prepare mouse-derived sp2 / 0 myeloma cells in advance so that the sp2 / 0 myeloma cells are in the logarithmic growth phase during fusion. Take the spleen of an immunized rabbit and prepare a single-cell suspension of lymphocytes; mix the rabbit spleen lymphocytes with the myeloma cells, add 50% PEG1500 dropwise, add IMDM culture medium, centrifuge and discard the supernatant, add HAT culture medium and gently suspend and mix, fix the volume to 800 mL, and then divide into 96-well plates and place in a 37°C, 5% CO2 constant temperature incubator for culture. After 6-9 days of fusion, observe the state of the fused cells in the 96-well plate, replace the medium with HT and continue to culture in a 37°C, 5% CO2 constant temperature incubator.
[0038] (4) Screening and cloning
[0039] 7-10 days after fusion, ELISA test was performed using P40 antigen (SEQ ID NO: 1) to screen cloned cells. The corresponding cell strain number was marked, and the positive well cells were limitedly diluted until the ELISA test result of the 96-well plate was positive. The monoclonal stable strain with a high positive value was selected to obtain the hybridoma cell strain that secreted specific monoclonal antibodies, which was recorded as 513M2A7.
[0040] (5) Perform antibody sequencing on the selected hybridoma cell lines
[0041] According to the instructions of the reagent TriZol, total RNA was isolated from 513M2A7 hybridoma cells, and according to the instructions of the TIANScript first-strand cDNA synthesis kit, the total RNA was reverse transcribed into cDNA, and the nucleotide sequences of the antibody heavy chain variable region and the antibody light chain variable region were amplified using specific primers (heavy chain variable region primer, VH-F: AGACTGGGCTGCGCTGGCTTC, VH-R GTGAGGGTGCCCGAG; light chain variable region primer: VK-FATGGACAYGAGGGCCCCCACTC, VK-R: GGTGGGAAGATGAGGACAGTAGG), and then the nucleotide sequences of the antibody heavy chain variable region and the antibody light chain variable region were cloned into eukaryotic expression vectors (InvivoGen, pfuse-rchg, pfuse2-rclk1) in preparation for cell transfection.
[0042] (6) Cell transfection and screening
[0043] Prepare the 293 cells to be transfected in advance, centrifuge and replace with fresh culture medium, and place them in 24-well plates, with 1.5 ml per well according to the required number, and the density is 3×10 6 Pieces / ml.
[0044] The eukaryotic expression vector and polyethyleneimine (PEI) were mixed at a mass ratio of 1:6 and added to the prepared 293 cells, and cultured in a shaker at 37°C and 5% CO2. After culturing for 3-5 days, the transfected cell supernatant was tested with the corresponding antigen by ELISA to screen the positive wells, and then the cell supernatant of the positive wells was further tested by immunohistochemistry. If the immunohistochemistry test was positive, it was confirmed that the detected antibody sequence was correct.
[0045] (7) Preparation and purification of monoclonal antibodies on cells
[0046] The positive expression vectors were transfected into a large number of cells, and after 3-5 days of continuous culture, the cell suspension was collected, the supernatant was taken after centrifugation, and the supernatant was purified by affinity chromatography using protein A to obtain antibodies with a purity of >95%. The purified monoclonal antibody concentration was measured, packaged, and stored in a refrigerator at 4-8°C.
[0047] Finally, the nucleotide sequence of the heavy chain variable region of the 513M2A7 anti-P40 recombinant rabbit monoclonal antibody is shown in SEQ ID NO:2, and the nucleotide sequence of the light chain variable region of the anti-P40 recombinant rabbit monoclonal antibody is shown in SEQ ID NO:3.
[0048] The specific sequences of SEQ ID NO: 2 and SEQ ID NO: 3 are as follows:
[0049] SEQ ID NO: 2 is:
[0050] cagtcggtggaggagtccgggggtcgcctggtcaagcctgacgaaaccctgacactcacctgcacagtctctggaatcgacctcagtagcaatgcaatgatctgggtccgccaggctccagggaaggggctggaatacatcggatacatttggagtggtggtagcaca ttctacgcgagctgggcaaaaggccgattcaccatctccaaaacctcgtcgaccacggtggatctgaaaatcaccagtccgacaaccgaggacacggccacctatttctgtgccagagggattgctggtggcatctggggcccaggcaccctggtcaccgtctcctca
[0051] SEQ ID NO: 3 is:
[0052] gatgttgtgatgacccagactccagcctccgtggaggcagctgtgggaggcacagtcaccatcaagtgccaggccagtcagaacatttacagcaatttagcctggtatcagcagaaaccagggcagcctcccaagctcctgatctattatgcatccactctggcctctg gggtcccatcgcggttcaaaggcagtagatctgggacagagttcactctcaccatcagcgacctggagtgtgccgatgctaccacttactactgtcaatgcacttctggtagtagtagtagtggtagttatggtggggctttcggcggagggaccgaggtggtggtcaaa
[0053] The obtained base sequence was translated into an amino acid sequence and analyzed to obtain the amino acid sequence of the heavy chain variable region of the 513M2A7 anti-P40 recombinant rabbit monoclonal antibody as shown in SEQ ID NO:4, and the amino acid sequence of the light chain variable region of the anti-P40 recombinant rabbit monoclonal antibody as shown in SEQ ID NO:5.
[0054] The specific sequences of SEQ ID NO: 4-5 are as follows:
[0055] SEQ ID NO: 4 is:
[0056] QSVEESGGRLVKPDETLTLTCTVSGIDLSSNAMIWVRQAPGKGLEYIGYIWSGGSTFYASWAKGRFTISKTSSTTVDLKITSPTTEDTATYFCARGIAGGIWGPGTLVTVSS
[0057] SEQ ID NO: 5 is:
[0058] DVVMTQTPASVEAAVGGTVTIKCQASQNIYSNLAWYQQKPGQPPKLLIYYASTLASGVPSRFKGSRSGTEFTLTISDLECADATTYYCQCTSGSSSSGSYGGAFGGGTEVVVK
[0059] Example 2
[0060] This example is an immunohistochemical detection using anti-P40 recombinant rabbit monoclonal antibody as the primary antibody, and the method is as follows:
[0061] (1) Sample slice preparation: Formalin-fixed paraffin-embedded lung squamous cell carcinoma, normal breast, and tonsil tissue slices were baked in a 60°C incubator for 1-2 h and stored for later use;
[0062] (2) Dewaxing of sections: Paraffin sections are first dewaxed in fresh xylene, soaking twice for 10 min each time;
[0063] (3) Hydration of sections: Soak in anhydrous ethanol, anhydrous ethanol, 95% ethanol, 85% ethanol, and 70% ethanol for 5 minutes in sequence for hydration, and then rinse with purified water twice, 3 minutes each time;
[0064] (4) Antigen repair: It is recommended to use high temperature heat repair method for 3 minutes (if using an automatic repair instrument, set the temperature to 98°C for 20 minutes). After the slices are naturally cooled to room temperature, circle the tissue to be tested with an immunohistochemistry pen and rinse with purified water twice, 3 minutes each time;
[0065] (5) Inactivation of endogenous peroxidase: drop an appropriate amount of endogenous peroxidase blocker to completely cover the tissue, incubate at room temperature for 10 min, rinse twice with purified water, 3 min each time, and rinse once with phosphate buffered saline (PBST);
[0066] (6) Primary antibody incubation: Add 100 μL of 1 μg / mL 513M2A7 anti-P40 recombinant rabbit monoclonal antibody to completely cover the tissue, incubate in a 37°C incubator for 1 h, and rinse with PBST 3 times, 5 min each time;
[0067] (7) Secondary antibody incubation: Perform secondary antibody incubation according to the instructions of the DAB staining solution kit of the secondary antibody staining system used. After incubation, rinse the slides three times with PBST, each time for 5 min, and rinse once with purified water;
[0068] (8) DAB staining: Prepare DAB staining solution according to the instructions of the DAB staining solution kit. Add an appropriate amount of DAB staining solution until the tissue is completely covered. Stop staining when the color does not deepen. Rinse with purified water three times.
[0069] (9) Hematoxylin counterstaining: Counterstain the sections according to the hematoxylin manufacturer's instructions and recommendations, and rinse with PBST or tap water to return to blue;
[0070] (10) Dehydration and transparency: Soak in 70%, 85%, 95%, 100%, and 100% alcohol in sequence, 3 min each time; and transparentize in xylene twice, 5 min each time;
[0071] (11) Sealing: Seal the samples with neutral gum.
[0072] Depend on Figure 1 The results show that P40 protein shows specific nuclear staining in human lung squamous cell carcinoma, normal breast, and tonsil tissues, and the staining effect of the P40 recombinant rabbit monoclonal antibody cloned by 513M2A7 is better than that of the commercially available P40 antibody, and the staining color is darker. This shows that the P40 recombinant rabbit monoclonal antibody cloned by 513M2A7 of the present invention is easier to evaluate in IHC staining due to its good specificity and strong positive signal, and is more accurate in detecting and distinguishing cancer.
[0073] Example 3
[0074] This example is a determination of the affinity of 513M2A7 anti-P40 recombinant rabbit monoclonal antibody, and the determination method is as follows:
[0075] (1) Take out the labeled P40 polypeptide (SEQ ID NO: 1) from 4°C and return to room temperature. Dilute to a concentration of 1 μg / ml, add 100 μL / well to a 96-well ELISA plate and incubate overnight at 4°C, then block with 2% bovine serum albumin (BSA) at 4°C overnight;
[0076] (2) The P40 recombinant rabbit monoclonal antibody cloned from 513M2A7 was diluted to an initial concentration of 0.5 μg / mL, and then diluted 2-fold in sequence, with a total of 8 concentration gradients for comparison;
[0077] (3) Add the diluted anti-P40 recombinant rabbit monoclonal antibody to the 96-well ELISA plate containing the peptide at 100 μL / well, cover with a sealing film, and incubate at 37°C for 1 h to allow the reaction to reach equilibrium;
[0078] (4) After the reaction is completed, remove the ELISA plate, discard the liquid, rinse it with purified water 5 times, and pat dry;
[0079] (5) Dilute horseradish peroxidase (HRP)-labeled goat anti-rabbit IgG according to the instructions for use of the secondary antibody, add 100 μL / well to the ELISA plate, and incubate at 37°C for 1 h to allow the reaction to reach equilibrium;
[0080] (6) After the reaction is completed, remove the ELISA plate, discard the liquid, rinse it with purified water 5 times, and pat dry;
[0081] (7) Add 3,3',5,5'-tetramethylbenzidine (TMB) colorimetric solution at 100 μL / well and react at room temperature for 6 minutes;
[0082] (8) After the reaction is completed, add 2M H2SO4 at 50 μL / well to stop the color development;
[0083] (9) Read the OD value at 450 nm on an ELISA reader and organize the data. The analysis results are as follows: Figure 2 shown.
[0084] The results showed that in 8 concentration gradient tests, the anti-P40 recombinant rabbit monoclonal antibody cloned by 513M2A7 of the present invention had a strong affinity and high sensitivity to the P40 protein molecule, and could still achieve a high OD value under conditions of lower antibody concentrations, thereby saving experimental and detection costs.
[0085] Example 4
[0086] This example is a Western blotting test using the anti-P40 recombinant rabbit monoclonal antibody 513M2A7 as the primary antibody, and the method is as follows:
[0087] (1) Activate the polyvinylidene fluoride (PVDF) membrane of HL-60 and HCT116 cell lysate with methanol for 1 min, wash the membrane twice with pure water and then wash it three times with TBST; Block: Place the membrane in a blocking solution prepared with 5% BSA and shake it at room temperature for 2 h; TBST is a commonly used washing buffer suitable for experiments such as immunoblotting. It contains three basic components: Tris buffer, salt (usually sodium chloride), and surfactant Tween-20;
[0088] (2) Primary antibody incubation: dilute the 513M2A7 antibody to a concentration of 0.5 μg / mL, place the blocked membrane in the corresponding diluted antibody, and incubate at 4°C with shaking overnight;
[0089] (3) Take out the membrane and wash it in TBST solution for 3 times (2×5min+1×10min);
[0090] (4) Secondary antibody incubation: dilute HRP-anti-rabbit IgG with FG solution at 1:5000, mix well, add to the membrane strip, and shake at room temperature for 1 h;
[0091] (5) Take out the membrane strip and wash it in TBST solution for 4 times (3×5min+1×8min);
[0092] (6) Substrate: Mix equal amounts of luminol / enhancer solution and hydrogen peroxide solution diluted 5-fold with pure water in the same container, add to the membrane strips, and incubate for 2 min.
[0093] (7) Exposure: Place the film in a dark box and expose it to X-rays for different time periods according to the fluorescence intensity. Then, develop it for 1 minute, wash it, and fix it for 1 minute. Finally, wash it and dry it. The results are as follows: Figure 3 As shown in the figure, HL-60 represents human acute promyelocytic leukemia cell lysate; HCT 116 represents human colon cancer cell lysate. Band size: 40 kDa.
[0094] Depend on Figure 3 The results show that in the swimming lane, the 513M2A7 anti-P40 recombinant rabbit monoclonal antibody can specifically recognize the P40 protein in human acute promyelocytic leukemia cells and colon cancer cells, with a molecular weight of about 40 kDa, indicating that the 513M2A7 cloned P40 recombinant rabbit monoclonal antibody of the present invention can recognize the P40 protein with high specificity.
[0095] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.
Claims
1. An anti-P40 recombinant rabbit monoclonal antibody, characterized in that: It comprises a heavy chain variable region and a light chain variable region, wherein the amino acid sequence of the heavy chain variable region is shown in SEQ ID NO: 4; and the amino acid sequence of the light chain variable region is shown in SEQ ID NO:
5.
2. A coding gene, characterized in that Used to encode the anti-P40 recombinant rabbit monoclonal antibody according to claim 1.
3. The coding gene according to claim 2, characterized in that It includes: The DNA sequence as shown in SEQ ID NO: 2 or a sequence complementary thereto is used to encode the heavy chain variable region of the anti-P40 recombinant rabbit monoclonal antibody, and the DNA sequence as shown in SEQ ID NO: 3 or a sequence complementary thereto is used to encode the light chain variable region of the anti-P40 recombinant rabbit monoclonal antibody.
4. A nucleic acid molecule, characterized in that It contains the coding gene according to claim 2 or 3.
5. An expression vector, characterized in that: It contains the nucleic acid molecule according to claim 4.
6. A host cell transformed or transfected with the expression vector according to claim 5.
7. A method for preparing an anti-P40 recombinant rabbit monoclonal antibody, characterized in that: The host cells are transformed or transfected with the expression vector described in claim 5, the cells are cultured continuously, the cell supernatant is collected and purified to obtain the anti-P40 recombinant rabbit monoclonal antibody.
8. Use of the anti-P40 recombinant rabbit monoclonal antibody according to claim 1, the encoding gene according to claim 2 or 3, the nucleic acid molecule according to claim 4, the expression vector according to claim 5, and the host cell according to claim 6 in preparing a P40 detection device.
9. A P40 detection kit, characterized in that: The invention comprises the anti-P40 recombinant rabbit monoclonal antibody according to claim 1 and an immunohistochemical detection reagent.
10. The P40 detection kit according to claim 9, characterized in that: The method comprises: anti-P40 recombinant rabbit monoclonal antibody, horseradish peroxidase labeled secondary antibody, ethylenediaminetetraacetic acid repair solution, catalase blocking solution, 3,3'-diaminobenzidine concentrated solution, 3,3'-diaminobenzidine buffer solution, hematoxylin and blueing solution.
Citation Information
Patent Citations
Monoclonal antibody for blocking 12p40 function of interleukin as well as coding gene and application thereof
CN103275222A
Tumor suppressor gene p63 monoclonal antibody and application thereof
CN104447994A
Anti-human p40 protein domain antibody and application thereof
CN112079922A
Anti-p40 protein monoclonal antibody, cell line and preparation method and use of anti-p40 protein monoclonal antibody
CN112409481A
